Kobayashi Financial Statements From 2010 to 2024

KBYPFDelisted Stock  USD 32.49  0.00  0.00%   
Kobayashi Pharmaceutical financial statements provide useful quarterly and yearly information to potential Kobayashi Pharmaceutical Co investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Kobayashi Pharmaceutical financial statements helps investors assess Kobayashi Pharmaceutical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Kobayashi Pharmaceutical's valuation are summarized below:
Kobayashi Pharmaceutical Co does not presently have any fundamental ratios for analysis.
Check Kobayashi Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kobayashi Pharmaceutical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Kobayashi financial statements analysis is a perfect complement when working with Kobayashi Pharmaceutical Valuation or Volatility modules.
  
This module can also supplement various Kobayashi Pharmaceutical Technical models . Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Kobayashi Pharmaceutical Co Company Return On Asset Analysis

Kobayashi Pharmaceutical's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Kobayashi Pharmaceutical Return On Asset

    
  0.0633  
Most of Kobayashi Pharmaceutical's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kobayashi Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Kobayashi Pharmaceutical Co has a Return On Asset of 0.0633. This is 111.0% higher than that of the Consumer Defensive sector and 98.88% lower than that of the Household & Personal Products industry. The return on asset for all United States stocks is 145.21% lower than that of the firm.

Kobayashi Pharmaceutical Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Kobayashi Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Kobayashi Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kobayashi Pharmaceutical competition to find correlations between indicators driving Kobayashi Pharmaceutical's intrinsic value. More Info.
Kobayashi Pharmaceutical Co is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about  0.65  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Kobayashi Pharmaceutical Co is roughly  1.53 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kobayashi Pharmaceutical's earnings, one of the primary drivers of an investment's value.

About Kobayashi Pharmaceutical Financial Statements

Kobayashi Pharmaceutical stakeholders use historical fundamental indicators, such as Kobayashi Pharmaceutical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Kobayashi Pharmaceutical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Kobayashi Pharmaceutical's assets and liabilities are reflected in the revenues and expenses on Kobayashi Pharmaceutical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Kobayashi Pharmaceutical Co. Please read more on our technical analysis and fundamental analysis pages.
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan. Kobayashi Pharmaceutical operates under Household Personal Products classification in the United States and is traded on OTC Exchange. It employs 3451 people.

Currently Active Assets on Macroaxis

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Consideration for investing in Kobayashi Pink Sheet

If you are still planning to invest in Kobayashi Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kobayashi Pharmaceutical's history and understand the potential risks before investing.
Global Correlations
Find global opportunities by holding instruments from different markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Bonds Directory
Find actively traded corporate debentures issued by US companies
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data